SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2xa7'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A4L_C_DCFC1353_2
(ADENOSINE DEAMINASE)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
4 / 5 LEU A 526
LEU A 487
LEU A 447
GLY A 500
None
0.89A 1a4lC-2xa7A:
undetectable
1a4lC-2xa7A:
19.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1D4Y_A_TPVA501_2
(PROTEIN (HIV-1
PROTEASE))
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
4 / 8 LEU B 396
ALA B 410
ILE B 451
ILE B 399
None
0.71A 1d4yB-2xa7B:
undetectable
1d4yB-2xa7B:
11.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FE2_A_LAXA700_1
(PROSTAGLANDIN
ENDOPEROXIDE H
SYNTHASE-1)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
5 / 10 VAL A 483
VAL A 425
VAL A 461
VAL A 465
LEU A 447
None
1.01A 1fe2A-2xa7A:
undetectable
1fe2A-2xa7A:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTB_A_PZQA901_0
(GLUTATHIONE
S-TRANSFERASE)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT
AP-2 COMPLEX SUBUNIT
BETA

(Rattus
norvegicus;
Homo
sapiens)
3 / 3 GLN B 481
TYR A 463
ARG A 464
None
0.62A 1gtbA-2xa7B:
2.6
1gtbA-2xa7B:
16.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ONI_C_BEZC505_0
(14.5 KDA
TRANSLATIONAL
INHIBITOR PROTEIN)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT
AP-2 COMPLEX SUBUNIT
BETA

(Rattus
norvegicus;
Homo
sapiens)
4 / 6 TYR B 524
ILE A 470
GLU A 506
ARG B 528
None
1.29A 1oniA-2xa7B:
undetectable
1oniC-2xa7B:
undetectable
1oniA-2xa7B:
12.28
1oniC-2xa7B:
12.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ONI_E_BEZE509_0
(14.5 KDA
TRANSLATIONAL
INHIBITOR PROTEIN)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT
AP-2 COMPLEX SUBUNIT
BETA

(Rattus
norvegicus;
Homo
sapiens)
4 / 7 TYR B 524
ILE A 470
GLU A 506
ARG B 528
None
1.14A 1oniD-2xa7B:
undetectable
1oniE-2xa7B:
undetectable
1oniD-2xa7B:
12.28
1oniE-2xa7B:
12.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OSV_B_CHCB201_1
(BILE ACID RECEPTOR)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
5 / 12 LEU B 396
ILE B 417
PHE B 418
ILE B 428
MET B 448
None
1.37A 1osvB-2xa7B:
0.0
1osvB-2xa7B:
16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK7_B_ADNB1246_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
4 / 8 GLY A 454
VAL A 457
GLU A 422
ILE A 450
None
0.89A 1pk7B-2xa7A:
undetectable
1pk7B-2xa7A:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RX3_A_MTXA161_2
(DIHYDROFOLATE
REDUCTASE)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
3 / 3 LYS A 434
ILE A 468
THR A 445
None
0.83A 1rx3A-2xa7A:
undetectable
1rx3A-2xa7A:
13.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TLM_A_MILA128_1
(TRANSTHYRETIN)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
3 / 3 LEU A 616
LEU A 613
SER A 610
None
0.64A 1tlmA-2xa7A:
undetectable
1tlmA-2xa7A:
11.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XOQ_B_ROFB501_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
3 / 3 MET B 110
ASN B  89
GLN B  59
None
1.00A 1xoqB-2xa7B:
undetectable
1xoqB-2xa7B:
19.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BDM_A_TMIA502_1
(CYTOCHROME P450 2B4)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
5 / 12 PHE A  97
ILE A  72
ASN A  34
LEU A  37
PHE A  44
None
0.97A 2bdmA-2xa7A:
undetectable
2bdmA-2xa7A:
23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXC_A_P1ZA2001_1
(SERUM ALBUMIN)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
5 / 12 LEU B 436
LEU B 465
ILE B 451
ILE B 429
ALA B 430
None
1.04A 2bxcA-2xa7B:
undetectable
2bxcA-2xa7B:
23.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BXQ_A_P1ZA2002_1
(SERUM ALBUMIN)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
5 / 12 LEU B 436
LEU B 465
ILE B 451
ILE B 429
ALA B 430
None
0.97A 2bxqA-2xa7B:
undetectable
2bxqA-2xa7B:
23.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VIN_A_505A1247_1
(UROKINASE-TYPE
PLASMINOGEN
ACTIVATOR CHAIN B)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
4 / 8 GLN A 476
VAL A 483
GLY A 505
GLY A 501
None
0.68A 2vinA-2xa7A:
undetectable
2vinA-2xa7A:
17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3APW_A_DP0A190_1
(ALPHA-1-ACID
GLYCOPROTEIN 2)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
5 / 12 VAL B 310
ILE B 306
PHE B 369
GLU B 337
ALA B 376
None
1.32A 3apwA-2xa7B:
undetectable
3apwA-2xa7B:
14.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EL0_A_1UNA201_2
(PROTEASE)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
5 / 9 LEU A 257
VAL A 309
ILE A 287
PRO A 253
ALA A 254
None
1.05A 3el0B-2xa7A:
undetectable
3el0B-2xa7A:
9.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GYQ_B_SAMB270_0
(RRNA
(ADENOSINE-2'-O-)-ME
THYLTRANSFERASE)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
5 / 11 LEU A 175
ALA A 169
ILE A 151
SER A 167
LEU A 132
None
1.21A 3gyqB-2xa7A:
undetectable
3gyqB-2xa7A:
18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HS6_B_EPAB1_2
(PROSTAGLANDIN G/H
SYNTHASE 2)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
4 / 7 VAL B 177
VAL B 181
LEU B 184
SER B 185
None
0.86A 3hs6B-2xa7B:
undetectable
3hs6B-2xa7B:
19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K37_B_BCZB468_1
(NEURAMINIDASE)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
3 / 3 ARG A 388
GLU A 423
TYR A 412
None
0.82A 3k37B-2xa7A:
undetectable
3k37B-2xa7A:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LP9_D_SPMD230_1
(LS-24)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
3 / 3 GLU B 544
GLU B 426
ASN B 423
None
0.90A 3lp9B-2xa7B:
undetectable
3lp9D-2xa7B:
undetectable
3lp9B-2xa7B:
17.40
3lp9D-2xa7B:
17.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MJR_D_AC2D601_1
(DEOXYCYTIDINE KINASE)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
4 / 8 TYR A 502
PHE A 507
GLN A 476
ASP A 473
None
1.12A 3mjrD-2xa7A:
undetectable
3mjrD-2xa7A:
17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N8Z_B_FLPB1701_1
(PROSTAGLANDIN G/H
SYNTHASE 1)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT
AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens;
Rattus
norvegicus)
5 / 12 TYR A 583
LEU B 507
ILE B 525
GLY B 523
LEU B 482
None
1.04A 3n8zB-2xa7A:
undetectable
3n8zB-2xa7A:
21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NT1_A_NPSA5_1
(PROSTAGLANDIN-ENDOPE
ROXIDE SYNTHASE 2)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
5 / 12 VAL B 244
LEU B 211
VAL B 255
ALA B 259
LEU B 263
None
0.97A 3nt1A-2xa7B:
undetectable
3nt1A-2xa7B:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NT1_B_NPSB4_1
(PROSTAGLANDIN-ENDOPE
ROXIDE SYNTHASE 2)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
5 / 12 VAL B 244
LEU B 211
VAL B 255
ALA B 259
LEU B 263
None
0.97A 3nt1B-2xa7B:
undetectable
3nt1B-2xa7B:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QT0_A_486A4_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
4 / 4 LYS B 318
GLN B 311
ILE B 564
LEU B 267
None
1.30A 3qt0A-2xa7B:
0.0
3qt0A-2xa7B:
20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZQT_A_TESA1000_1
(ANDROGEN RECEPTOR)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
5 / 12 LEU A 541
LEU A 526
LEU A 525
GLN A 488
VAL A 483
None
1.33A 3zqtA-2xa7A:
undetectable
3zqtA-2xa7A:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AZT_A_SAMA1472_0
(METHYLTRANSFERASE
WBDD)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
5 / 12 ALA A  79
ASN A  81
ILE A 112
LEU A 101
ILE A 109
None
0.96A 4aztA-2xa7A:
undetectable
4aztA-2xa7A:
23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AZV_A_SAMA1474_0
(WBDD)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
5 / 12 ALA A  79
ASN A  81
ILE A 112
LEU A 101
ILE A 109
None
0.95A 4azvA-2xa7A:
undetectable
4azvA-2xa7A:
23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CCQ_A_ACTA1317_0
(THIOREDOXIN
REDUCTASE)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
3 / 3 LEU B 465
GLU B 464
SER B 468
None
0.76A 4ccqA-2xa7B:
undetectable
4ccqA-2xa7B:
19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1Y_A_RBFA1176_1
(PUTATIVE PROTEASE I)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
4 / 8 GLN A 333
ASN A 307
ASN A 289
THR A 286
None
1.45A 4d1yA-2xa7A:
undetectable
4d1yB-2xa7A:
undetectable
4d1yA-2xa7A:
13.94
4d1yB-2xa7A:
13.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EM2_A_SALA504_1
(UNCHARACTERIZED
HTH-TYPE
TRANSCRIPTIONAL
REGULATOR SAR2349)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
4 / 8 PHE A 548
GLY A 505
LEU A 504
ILE A 503
None
0.86A 4em2A-2xa7A:
undetectable
4em2A-2xa7A:
14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4GH8_A_MTXA201_2
(DIHYDROFOLATE
REDUCTASE)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
3 / 3 LYS A 434
ILE A 468
THR A 445
None
0.87A 4gh8A-2xa7A:
undetectable
4gh8A-2xa7A:
13.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HXY_B_ACAB502_1
(PLM1)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
4 / 7 VAL A 390
GLN A 387
MET A 409
LEU A 413
None
1.07A 4hxyB-2xa7A:
undetectable
4hxyB-2xa7A:
21.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LV9_A_20JA602_1
(NICOTINAMIDE
PHOSPHORIBOSYLTRANSF
ERASE)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
4 / 7 VAL A 390
ILE A 424
ILE A 420
ALA A 416
None
0.87A 4lv9A-2xa7A:
undetectable
4lv9A-2xa7A:
22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LV9_B_20JB602_1
(NICOTINAMIDE
PHOSPHORIBOSYLTRANSF
ERASE)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
4 / 7 VAL A 390
ILE A 424
ILE A 420
ALA A 416
None
0.86A 4lv9B-2xa7A:
undetectable
4lv9B-2xa7A:
22.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PCL_A_SAMA301_0
(O-METHYLTRANSFERASE
FAMILY PROTEIN)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
5 / 12 LEU A 526
GLY A 508
PHE A 523
ASP A 514
ALA A 480
None
1.22A 4pclA-2xa7A:
undetectable
4pclA-2xa7A:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q0B_A_NVPA901_1
(HIV-1 REVERSE
TRANSCRIPTASE, P66
SUBUNIT)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
4 / 8 LEU B 130
VAL B 176
VAL B 137
LEU B 165
None
1.16A 4q0bA-2xa7B:
undetectable
4q0bA-2xa7B:
24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R38_A_RBFA201_2
(BLUE-LIGHT-ACTIVATED
HISTIDINE KINASE 2)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
4 / 8 ILE A 470
VAL A 461
ILE A 612
PHE A 605
None
0.79A 4r38A-2xa7A:
undetectable
4r38A-2xa7A:
12.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4X3M_B_ADNB301_1
(RNA 2'-O RIBOSE
METHYLTRANSFERASE)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
5 / 9 LEU B 257
GLY B 568
ILE B 306
LEU B 303
VAL B 301
None
1.06A 4x3mB-2xa7B:
undetectable
4x3mB-2xa7B:
18.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DQF_A_LCRA612_1
(SERUM ALBUMIN)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
5 / 9 LEU A 334
GLY A 335
LEU A 338
LEU A 350
ALA A 349
None
0.93A 5dqfA-2xa7A:
undetectable
5dqfA-2xa7A:
22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E8Q_A_FOLA201_1
(DIHYDROFOLATE
REDUCTASE)
2xa7 AP-2 COMPLEX SUBUNIT
BETA

(Homo
sapiens)
3 / 3 ASP B 158
LEU B 197
ARG B 166
None
0.78A 5e8qA-2xa7B:
undetectable
5e8qA-2xa7B:
13.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECN_D_LEUD602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT
AP-2 COMPLEX SUBUNIT
BETA

(Rattus
norvegicus;
Homo
sapiens)
5 / 8 ALA B 487
THR B 486
VAL B 489
TYR B 526
GLU A 575
None
1.49A 5ecnD-2xa7B:
undetectable
5ecnD-2xa7B:
22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LG3_I_Z80I401_1
(GAMMA-AMINOBUTYRIC-A
CID RECEPTOR SUBUNIT
BETA-1)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
4 / 9 ILE A 452
ASN A 495
ASP A 455
ILE A 450
None
0.90A 5lg3I-2xa7A:
1.1
5lg3I-2xa7A:
20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AJI_A_AY6A1001_0
(DRUG EXPORTERS OF
THE RND
SUPERFAMILY-LIKE
PROTEIN,ENDOLYSIN)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
5 / 12 ILE A  72
ILE A  40
VAL A  59
LEU A  63
LEU A 101
None
1.06A 6ajiA-2xa7A:
undetectable
6ajiA-2xa7A:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BZO_C_FI8C1201_0
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT
AP-2 COMPLEX SUBUNIT
BETA

(Rattus
norvegicus;
Homo
sapiens)
5 / 12 ILE B 548
GLN A 577
VAL B 541
GLU A 575
VAL A 535
None
1.30A 6bzoC-2xa7B:
undetectable
6bzoC-2xa7B:
19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HLO_A_GBQA1501_1
(SUBSTANCE-P
RECEPTOR,GLGA
GLYCOGEN
SYNTHASE,SUBSTANCE-P
RECEPTOR)
2xa7 ADAPTOR-RELATED
PROTEIN COMPLEX 2,
ALPHA 2 SUBUNIT

(Rattus
norvegicus)
5 / 9 ASN A 509
ILE A 503
ILE A 470
VAL A 499
ILE A 466
None
1.43A 6hloA-2xa7A:
undetectable
6hloA-2xa7A:
21.19